Roche presented the latest data for its experimental multiple sclerosis drug, setting the stage for the company to seek FDA approval.
Pharmalittle: Medicare drops obesity drug pilot, Roche touts MS data
Roche presented the latest data for its experimental multiple sclerosis drug, setting the stage for the company to seek FDA approval.